NDC product
Benadryl Allergy Extra Strength Liqui-Gels
NDC 50580-322 · Kenvue Brands LLC
Key facts
| Product NDC | 50580-322 |
|---|---|
| Proprietary name | Benadryl Allergy Extra Strength Liqui-Gels |
| Nonproprietary name | Diphenhydramine Hydrochloride |
| Substances | DIPHENHYDRAMINE HCL |
| Dosage form | CAPSULE, LIQUID FILLED |
| Route | ORAL |
| Labeler | Kenvue Brands LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| Marketing start | May 15, 2025 |
| Marketing end | Apr 30, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory